Seattle startup Receptor Life Sciences has raised $9.7 million to move its CBD-based therapeutic candidate for acute anxiety through clinical testing. The company is developing a dry powdered form of… Read More
Secretive biotechnology company Receptor Life Sciences has raised a funding round totaling just over $7.5 million, according to a filing with the Securities and Exchange Commission. A representative of the Seattle-area… Read More